© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Global
COVID-19: Expanding Remote Patient Services during Lockdown
July 20, 2020
Stephanie Hill looks at the efforts made by patient solutions providers in the UK to build and support services outside the hospital environment during the pandemic.
Is Drug Production Heading Back to Europe From Abroad?
July 09, 2020
Pharmaceutical Executive
Pandemic sparks call for European manufacturing renaissance.
The Specter of Compulsory Licensing Haunts Vaccine Debate
June 11, 2020
Industry prospects at mercy of public discourse, policy shifts.
A New, Less Friendly Normal Looms for European Drugmakers
May 10, 2020
Pharmaceutical Executive
Pandemic fallout could spell fundamental business and policy shifts.
Iraq: Stabilizing a Growing Market
May 06, 2020
Ali Mosawi writes about the misconceptions of Iraq's often inhospitable landscape, the essential role of international expertise in driving growth, and how the sector has adapted to meet the challenges of the COVID-19 pandemic.
There’s No Easing the Price-vs.-Value Debate
April 08, 2020
Pharmaceutical Executive
With coronavirus a stark backdrop, European initiative pushes for “fair” drug prices to spur investment in pharma innovation.
Getting through the EU MDR and IVDR Whirlwind: Steps to Compliance
March 11, 2020
Medical devices manufacturers and pharma companies alike should review their compliance strategies as the EU Medical Device Regulation Date of Application approaches.
Blood Feud Divides Europe Over Plasma Shortfalls
March 09, 2020
Pharmaceutical Executive
The collection of source plasma for new therapies igniting debate.
Chemotherapy vs Immunotherapy: China's Liver Cancer Market Outlook
March 09, 2020
Jianan Huang outlines the market prospects for first-line treatments for liver cancer treatment in China.